Studies were performed to determine if the unique N-terminal domain of the R1 subunit from herpes simplex virus (HSV) type 1 ribonucleotide reductase is a substrate for casein kinase 2 (CK2). Transphosphorylation assays demonstrated that R1 was highly phosphorylated by this enzyme with multiple phosphorylation sites mapped to the N terminus between residues 1 and 245. Immunoprecipitation pull-down assays using R1-specific antisera failed to demonstrate a stable interaction between R1 and CK2 but residual amounts of CK2 present after immunoprecipitation efficiently transphosphorylated R1. Activity assays with a peptide substrate identified CK2 in R1 immunoprecipitated from infected-cell extracts but did not detect activity in R1 proteins immunoprecipitated from bacterial extracts. However, Western blotting identified potential E. coli homologues of the CK2 alpha and beta subunits. These results support conclusions that the N-terminal domain of HSV R1 is not a protein kinase and that all previous results can be explained by contaminating kinases, principally CK2.
Studies were performed to determine if the unique N-terminal domain of the R1 subunit from herpes simplex virus (HSV) type 1 ribonucleotide reductase is a substrate for casein kinase 2 (CK2). Transphosphorylation assays demonstrated that R1 was highly phosphorylated by this enzyme with multiple phosphorylation sites mapped to the N terminus between residues 1 and 245. Immunoprecipitation pull-down assays using R1-specific antisera failed to demonstrate a stable interaction between R1 and CK2 but residual amounts of CK2 present after immunoprecipitation efficiently transphosphorylated R1. Activity assays with a peptide substrate identified CK2 in R1 immunoprecipitated from infected-cell extracts but did not detect activity in R1 proteins immunoprecipitated from bacterial extracts. However, Western blotting identified potential E. coli homologues of the CK2 alpha and beta subunits. These results support conclusions that the N-terminal domain of HSV R1 is not a protein kinase and that all previous results can be explained by contaminating kinases, principally CK2.
Conversion of ribonucleotides to the corresponding deoxyribonucleotides by ribonucleotide reductase (RR) is essential for the de novo synthesis of DNA in all living organisms (Reichard, 1993) . Many herpesviruses encode their own RR and the active form is a tetramer of homodimeric R1 and R2 subunits (reviewed in . RR activity is a target for antiviral chemotherapy and has provided a paradigm to study peptides which disrupt protein-protein interactions as a route to the development of antiviral drugs (Dutia et al., Author for correspondence : Joe Conner.
Fax j44 141 331 3208. e-mail J. Conner!gcal.ac.uk 1986 ; Cohen et al., 1986 ; Marcello et al., 1994 ; Liuzzi et al., 1994) . In addition to their involvement in RR activity, the R1 subunits of herpes simplex virus (HSV) types 1 and 2 have been reported to possess a serine\threonine phosphokinase (PK) activity (R1PK) Paradis et al., 1991 ; Cooper et al., 1995) that is distinct from conventional eukaryotic kinases. The novel kinase activity is thought to be located within the N-terminal 310 amino acids, a domain which is unique to HSV R1 and is not required for ribonucleotide reduction (Conner et al., b, 1993 Lankinen et al., 1993) ; also, its role in HSV replication\ pathogenesis is not yet established. Protein R1 is essential for virus pathogenicity as evidenced by the avirulence and failure to reactivate from latency of deletion mutants (Cameron et al., 1988 ; Jacobson et al., 1989 ; Yamada et al., 1991 ; Heineman & Cohen, 1994 ; deWind et al., 1993) which could reflect either the lack of RR or N-terminal activity or of both.
The HSV R1 subunits are synthesized in infected tissue culture cells with immediate-early kinetics, in contrast to R2 which is an early protein (Clements et al., 1977 ; Wymer et al., 1989 ; Conner et al., 1995) . During infection the R1 promoter is uniquely regulated : expression is induced by the immediateearly transactivator Vmw65 (VP16) and, intriguingly, by Vmw110 (ICP0) (Desai et al., 1993) , a viral transactivator required for efficient reactivation from latency (Clements & Stow, 1989 ; Leib et al., 1989 ; Russell et al., 1987) . Interestingly, the R1 promoter contains functional response elements for cellular activator protein 1 (AP-1) (Wymer et al., 1992 ; Zhu & Aurelian, 1997) , a bipartite complex of two cellular immediateearly proteins, c-Fos and c-Jun. HSV-1 R1 is twice as abundant as R2 in infected cells and the intracellular localization of the free R1 is distinct from that of the active enzyme . These data have been used to propose a role for R1 additional to its involvement in RR that requires the phosphorylation of viral\cellular proteins during immediateearly times by the putative N-terminal protein kinase (R1PK).
However, there are a number of discrepancies relating to the putative R1PK (see Peng et al., 1996) and these have culminated in a recent proposal by Langelier et al. (1998) the R1 subunit is not a PK but is a good substrate for host cell PKs, particularly casein kinase 2 (CK2). The results presented here support this observation and strengthen the conclusion that the N terminus of HSV R1 is not a protein kinase. Analysis by SDS-PAGE and autoradiography of bacterially expressed HSV-1 R1 (1R1) immunoprecipitated by antiserum 106 from ammonium sulphate fractions as described in Cooper et al. (1995) in the presence of increasing amounts of purified Drosophila CK2 indicated that R1 was a substrate for this kinase (Fig. 1, lanes 1-6) . CK2 was added before immunoprecipitation and, after extensive washing, phosphorylation was determined by addition of 30 µl of CK2 assay buffer (50 mM Tris-HCl buffer, pH 8n2, 20 mM MgCl # ) with 1µl [$#P]ATP to the Protein A-Sepharose pellet. After incubation at 25 mC for 30 min, the pellet was washed once with CK2 assay buffer and $#P incorporation was observed by SDS-PAGE and autoradiography. The levels of 1R1 phosphorylation increased with increasing amounts of CK2 ; Fig. 1 , lane 1 shows an immunoprecipitated control bacterial extract and lanes 2-6 show phosphorylation of 1R1 after immunoprecipitation in the absence (lane 2) or presence of 0n5 (lane 3), 1 (lane 4), 2 (lane 5) or 4 µg (lane 6) CK2. Bacterially expressed and purified 1R1 was readily phosphorylated also by CK2 (Fig. 1, lanes 7-16) . Duplicate 5 µg 1R1 samples were incubated alone or with increasing amounts of CK2 ; 1R1 ' autophosphorylation' (lanes 7 and 8) was only observed after longer exposures of the gel to autoradiograph film (not shown) whereas lanes 9-16 readily show transphosphorylation by 0n9 (lanes 9 and 10), 1n8 (lanes 11 and 12), 3n6 (lanes 13 and 14) and 7n2 ng (lanes 15 and 16) CK2.
The majority of CK2 phosphorylation sites were mapped to the N-terminal domain of 1R1. Immunoprecipitated dN245R1, a polypeptide lacking the first 244 amino acids , was a poor substrate for CK2 (Fig. 1, lane  17) whereas the immunoprecipitated, C-terminally truncated 1R1 protein, dC449R1, comprising residues 1-448 (Cooper et al., 1995) , was phosphorylated (Fig. 1, lane 18) . Surprisingly, in112R1, a variant on dC449R1 with a four amino acid insert at residue 112 that abrogated R1PK activity (Cooper et al., 1995) , was a poor CK2 substrate (Fig. 1, lane 19) whereas in343R1, a PK ' active ' variant of dC449R1 with the same four amino acid insert at residue 343 was phosphorylated (lane 20). The proteins were immunoprecipitated from ammonium sulphate fractions in the presence of 4 µg CK2 ; antiserum 106 immunoprecipitates approximately equal amounts of all four polypeptides (Cooper et al., 1995) . Tryptic digestion (Conner et al., 1992 b) of CK2-phosphorylated 1R1 generated 87 kDa C-terminal and 33 kDa N-terminal fragments and the majority of $#P was detected in the N-terminal fragment (data not shown).
Experiments using immunoprecipitation assays were performed to determine whether there was a stable physical interaction between R1 and CK2. CK2 was added to 1R1 ammonium sulphate fractions and, after immunoprecipitation with antiserum 106, the immunocomplexed proteins were analysed by SDS-PAGE and Western blotting using antiserum specific for the CK2 alpha or beta subunits : no evidence of any interaction was detected (data not shown). Further interaction studies, using a more sensitive and quantitative phosphorylation assay with a CK2 substrate peptide, RRREEETEEE, were undertaken. Protein 1R1 was immunoprecipitated from bacterial extracts by either antiserum 106 or MAb7689 in the presence of 8 µg CK2. After extensive washes, amounts of CK2 in the immunoprecipitates were * 1n1 µg 1R1 is immunoprecipitated from bacterial extracts by these antibodies (Cooper et al., 1995) . † CK2 was added to the 1R1 ammonium sulphate fraction prior to immunoprecipitation. ‡ CK2 pulled down was calculated from the levels of peptide phosphorylation using a calibration curve. § Molecular masses for molar ratio determinations were as follows : 1R1, 140 000 kDa ; CK2, 65 000 kDa. determined by peptide phosphorylation and the results are presented in Table 1 . Less than 1 % of the available CK2 was pulled down suggesting that there is no strong interaction between R1 and CK2. Molar ratios of R1 : CK2 were calculated from estimates of the amounts of 1R1 and CK2 in immunoprecipitates and, although the resultant values must be treated with some caution, the expected 1 : 1 ratio for a stable R1-CK2 complex was not obtained ; 8 µg CK2 is a 15-fold molar excess over immunoprecipitated R1. Despite the lack of interaction, the residual amounts of CK2 present after immunoprecipitation transphosphorylated 1R1 (see Fig. 1 , lanes 3-6) R1 proteins immunoprecipitated from infected cell and bacterial extracts were investigated for CK2 contamination using peptide phosphorylation assays (Fig. 2 a) . Levels of peptide phosphorylation were determined in duplicate samples of 1R1, HSV-2 R1 (2R1) and dN245R1 immunoprecipitated by antiserum 106 from bacterial extracts and in an immunoprecipitated control extract but no CK2 activity was evident ; the levels of $#P detected were consistent with background for this assay. Background levels of phosphorylation were higher in 1R1 immunoprecipitated from infected cell extracts but this higher level of $#P incorporation was augmented in the presence of the CK2 peptide indicating that this sample contained contaminant CK2 activity ; a similar level of phosphorylation was obtained with 1 ng CK2. The ammonium sulphate fractions from bacterial and infected-cell extracts used for 1R1 immunoprecipitation were analysed by Western blotting with antisera specific for either CK2 alpha or beta (Fig.  2 b) and both alpha (lane 4) and beta (lane 1) subunits were detected in infected cell extracts. Surprisingly, a band cor-responding to the CK2 beta subunit was detected in the bacterial extract (lane 2) and, amongst several cross-reactive bands that were detected with the alpha subunit antiserum (lane 3), one corresponded to CK2 alpha.
Protein kinase activity was first described for 2R1 by Chung et al. (1989) and for 1R1 by Paradis et al. (1991) . Their initial studies used proteins that were either immunoprecipitated or purified from infected-cell extracts. Since these first reports a number of other results, including expression of the ' active ' R1PK in E. coli and mutagenesis studies Cooper et al., 1995 ; Luo & Aurelian, 1992 ; Luo et al., 1991) , have consistently demonstrated apparent intrinsic autophosphorylation activity that resides within the Nterminal domain despite a lack of conventional eukaryotic protein kinase motifs. However, there were some inconsistencies concerning R1PK transphosphorylation of eukaryotic protein kinase substrates. Studies have reported phosphorylation of histones, casein and calmodulin by 1R1 and 2R1 (Chung et al., 1990 ; Paradis et al., 1991 ; Luo et al., 1991) . In contrast, , Cooper et al. (1995) and Ali (1995) consistently failed to detect transphosphorylation of any of these substrates. Indeed, and Cooper et al. (1995) reported a contaminant E. coli protein kinase which phosphorylated histones in their R1 preparations and these authors recommended caution in the interpretation of any R1PK results. Peng et al. (1996) attempted to reconcile these inconsistencies by differences in the optimal assay conditions for the 1R1 and 2R1 PKs but the discrepancies have resulted in speculation that R1 PK activity is due to contaminant kinases, particularly CK2 (see discussion in Smith et al., 1996) . This proposal was confirmed by Langelier et al. (1998) in experiments that convincingly demonstrate the following : (1) highly purified preparations of R1 are almost totally devoid of PK activity, (2) R1 has a very low affinity for ATP and (3) the N terminus is a substrate for CK2 which can phosphorylate R1 even after SDS-PAGE and renaturation on blot. This study supports and extends Langelier's findings by demonstrating that trace amounts of CK2 present in R1 immunoprecipitated from mammalian or bacterial extracts can give misleading ' autophosphorylation' results in the frequently used immunocomplex kinase assay. These results therefore strengthen the conclusion that the HSV R1 N terminus is not a protein kinase by confirming that all previous results in both eukaryotic and prokaryotic systems can be explained by contaminant kinase activities, principally CK2.
CK2 is a ubiquitous serine\threonine kinase present in both the nucleus and cytoplasm of eukaryotic cells. The enzyme is a tetramer comprising two non-identical alpha and beta homodimers with monomeric molecular masses of 40 and 25 kDa respectively. The alpha subunit provides the phosphotransferase function of the enzyme and the beta subunit, which is autophosphorylated, plays a regulatory role (for review see Edelman et al., 1987) . CK2 has many nuclear and cytoplasmic substrates and may act to regulate the activity, stability and\or intracellular location of many cell growth control proteins. The beta subunit is involved in protein-protein interactions with substrates and has been shown to form a stable complex with two of these, p53 (Filhol et al., 1992) and DNA topoisomerase II (Bojanowski et al., 1993) .
Initial experiments demonstrated that 1R1 was an excellent substrate for CK2 and the majority of 1R1 phosphorylation sites were mapped to the N-terminal domain between residues 1 and 245. CK2 can phosphorylate either serines or threonines at a variety of motifs with a broad consensus of S\TXXD\EX, although, in the majority of sites, there are three consecutive acidic residues following the phosphate acceptor (Pearson & Kemp, 1991) . Located within the N termini of both 1R1 and 2R1 is a conserved block of residues (amino acids 190-237) consisting mostly of serines and aspartic acids and this probably provides CK2 phosphorylation sites. The highly conserved region could be functionally important and CK2 phosphorylation of serines may regulate an activity of the Nterminal domain in vivo. Langelier et al. (1998) proposed that R1 and CK2 may interact but results presented here consistently provided no evidence for a stable interaction between R1 and CK2. Strikingly, they indicated that 1R1 was readily phosphorylated by trace amounts of CK2 contaminating the immunoprecipitates and suggest an alternative explanation for the mutagenesis studies by Cooper et al. (1995) in which four amino acid inserts at residues 22 and 112 abrogated R1PK activity whereas similar insertions at residues 257, 262, 292 and 343 had no effect. Immunoprecipitated in112R1, the polypeptide with a four amino acid insert at residue 112, was a poor substrate for CK2, possibly because the insert affected its structural integrity resulting in the inefficient display of phosphate acceptor sites. The same insertion at residue 343 caused no structural alterations that affected CK2 phosphorylation.
Peptide phosphorylation assays identified CK2 contamination of 1R1 immunoprecipitated from infected cell extracts but failed to detect any CK2 activity in R1 proteins immunoprecipitated from bacterial extracts. However, Western blotting indicated the presence of potential CK2 alpha and beta subunits in bacterial extracts suggesting the existence of a prokaryotic CK2 homologue, although further studies will be needed to confirm this. The peptide phosphorylation assay was optimized for the eukaryotic enzyme and the putative E. coli kinase may not be fully active under these conditions ; its phosphorylation motifs and\or cation and pH requirements may differ. Such differences would explain the low levels of activity consistently detected with bacterially expressed R1 proteins Cooper et al., 1995 ; Langelier et al., 1998) , since R1 would not be efficently phosphorylated by E. coli CK2.
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